InsidersTradesSigma
Track the 凯普生物 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 凯普生物 has logged 3 insider filings. Market capitalisation: €3.5bn. The latest transaction was disclosed on 9 January 2026 (Purchase). Among the most active insiders: 谢龙旭. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
凯普生物是一家专注于医疗保健和制药领域的公司，专门从事生物制药解决方案的开发。该公司在 XSHE 市场上市。